60 Degrees Pharmaceuticals, Inc. (SXTP) Financials

$0.97

$-0.02 (-2.29%)

As on 18-Sep-2026 13:36EDT

Market cap

$3 Mln

Revenue (TTM)

$1 Mln

P/E Ratio

--

P/B Ratio

0

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	1.11	1.01	0.61	0.25	0.22	1.16
Cost of Revenue	0.90	0.78	0.38	0.47	0.43	0.85
Gross Profit	0.22	0.22	0.22	-0.22	-0.21	0.31
Operating Expenses	8.82	7.98	9.94	4.93	1.54	1.43
Operating Profit (EBIT)	-8.61	-7.76	-9.71	-5.15	-1.75	-1.12
Other Income	--	--	--	--	--	--
Profit before Tax	-8.11	-7.37	-7.96	-3.81	-6.18	-4.26
Provision for Tax	0.00	--	0.00	0.00	0.00	0.00
Profit after Tax (Net Income)	-8.11	-7.37	-7.95	-3.77	-6.18	-4.25
Minority Interest	0.00	0.00	0.01	0.01	0.00	0.01
Consolidated Profit	--	--	--	--	-6.18	-6.18

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	2.61	3.46	4.04	4.87	-23.58	-17.58
Minority Interest	0.00	--	--	--	--	--
Non-Current Liabilities	0.15	0.14	0.15	0.15	1.53	18.91
Current Liabilities	1.61	1.84	1.66	2.84	23.92	0.64
Total Liabilities	5.89	5.37	5.76	7.78	1.30	1.39

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	0.55	0.47	0.37	0.54	0.20	0.22
Current Assets	3.73	4.90	5.39	7.24	1.10	1.18
Total Assets	5.89	5.37	5.76	7.78	1.30	1.39
Total Debt*	0.15	0.15	0.16	0.17	22.42	18.80
Net Current Assets	2.13	3.05	3.73	4.41	-22.82	0.54

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-6.85	-5.65	-4.54	-1.01	-0.65
Cash Flow from Investing Activities	--	0.25	-1.89	-0.12	-0.06	-0.04
Cash from Financing Activities	--	6.44	7.05	6.47	1.22	0.61
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-5.82	-6.34	-56.08	-0.65	-255.44	-175.69
Cash EPS ($)	--	-6.26	-55.63	-0.63	-252.19	-172.73
Adjusted Book Value ($)	--	2.98	28.48	0.84	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-5.89	-39.86	-0.78	-41.73	-26.82
Free Cash Flow per Share ($)	--	-6.08	-41.14	-0.80	-44.22	-28.29

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-188.75	-172.12	-193.89	-18,202.14	-296.77
ROE (%)	-266.88	-196.52	-178.47	40.26	30.04	24.24
ROA (%)	-137.97	-132.46	-117.36	-82.94	-459.48	-212.61
EBIT Margin (%)	-730.17	-732.05	-1,308.07	-602.16	-980.22	-93.64
Net Margin (%)	-730.23	-732.82	-1,308.01	-1,485.06	-2,769.49	-366.42
Cash Profit Margin (%)	-0.01	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	68.02	0.65	1.40	0.14	-0.81	-0.47
EBIT Growth (%)	-3.81	7.39	-420.49	30.21	-101.36	-194.44
Net Profit Growth (%)	-3.80	7.28	-111.04	39.08	-45.39	-40.15
EPS Growth (%)	86.36	0.89	-85.53	1.00	-0.45	--
Book Value Growth (%)	-85.06	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-0.08	-0.02	-1.57	--	--
Price / Book Value	--	0.17	0.05	1.22	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	22.23	0.28	0.39	-2.77	--	--
Close Price ($)	1.76	2.03	25.80	244.80	--	--
High Price ($)	10.77	32.00	271.18	2,076.00	--	--
Low Price ($)	1.23	1.80	14.03	--	--	--
Market Cap ($ Cr)	3.17	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	0.06	0.04	0.04	0.04	-0.95	-1.07
Short term debt to equity ratio	0.00	0.00	0.00	0.00	-0.90	-0.01
Current Ratio	2.32	2.66	3.25	2.55	0.05	1.85
Quick Ratio	1.78	2.30	2.98	2.39	0.02	0.77
Interest Coverage	-1,068.52	-943.05	-1,004.49	-0.67	-0.55	-0.34

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	51.04	50.69	80.11	91.23	20.59	12.61
Asset Turnover	0.19	0.18	0.09	0.06	0.17	0.58
Receivable days	--	180.98	215.84	199.71	157.36	158.30
Inventory Days	--	256.92	431.42	378.97	510.08	371.08
Payable days	--	576.33	718.52	486.77	569.09	421.96
Cash Conversion Cycle	--	-138.44	-71.26	91.91	98.34	107.41

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.